XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($)
$ in Millions
4 Months Ended
Jun. 19, 2021
Jun. 20, 2020
Concentration Risk [Line Items]    
Net sales and other revenue $ 21,269.4 $ 22,751.6
Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 21,269.4 $ 22,751.6
Percentage of total net sales and other revenue 100.00% 100.00%
Non-perishables | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 9,270.3 $ 10,783.8
Percentage of total net sales and other revenue 43.60% 47.40%
Perishables | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 8,912.6 $ 9,555.6
Percentage of total net sales and other revenue 41.90% 42.00%
Pharmacy | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 1,728.6 $ 1,554.9
Percentage of total net sales and other revenue 8.10% 6.80%
Fuel | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 1,049.3 $ 589.2
Percentage of total net sales and other revenue 4.90% 2.60%
Other | Product Line | Product Concentration Risk    
Concentration Risk [Line Items]    
Net sales and other revenue $ 308.6 $ 268.1
Percentage of total net sales and other revenue 1.50% 1.20%